Form4insider filings, from the source

Company · CIK 0001580149 · SIC 2834 — Pharmaceutical Preparations · Nasdaq

BIOVIE INC. · BIVI

Insider activity reported against this company. All insider holders · On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted
Open-market buys & salesbuys $49k · 4sales $0 · 0net $49k
$10k$10k$100k$100k$1M$1MbuyssalesSep 2024Jan 2025May 2025Sep 2025Jan 2026May 2026Sep 2026

Reported at this company — common stock

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Aug 28, 2026 PForm 4 →Aug 28, 9:01 pm EDTJoseph M PalumboChief Medical Officer4,843$2.16$10,4616,036+406%
Aug 28, 2026 PForm 4 →Aug 28, 9:01 pm EDTAmy Suzon ChappellDirector727$2.16$1,570727—
Aug 28, 2026 PForm 4 →Aug 28, 8:58 pm EDTJoanne Wendy KimChief Financial Officer2,500$2.18$5,4503,441+266%
Aug 27, 2026 PForm 4 →Aug 28, 8:57 pm EDTCuong V DoPresident & CEO, Director15,210$2.08$31,63716,117+1,677%

Reported at this company — derivatives (options, RSUs, warrants)

No reported derivative activity in this period.